Medcast news and blog
Breaking down the latest in gout care
Australian Therapeutic Guidelines for the management of gout have recently been updated to reflect current evidence. Rheumatologist Dr Alana Bruce explains what prescribers and other HPs should know about these updates to ensure optimal care for their patients with gout.
READ ON
Diet and alcohol intake are no longer thought to play as big a role in gout as previously thought, yet patients with gout often show great interest in how they can improve their diet. Below are answers to common myths.

Gout, a common yet preventable condition, is not as benign as once thought. While it has long been suggested that people with gout are at increased risk of cardiovascular disease and mortality, the association has been complex and unclear. Recent evidence has improved our understanding of this link.

In this podcast Dr Kate Annear and Professor Ric Day, rheumatologist and clinical pharmacologist, will cover why gout is important, and will also address some of the common misconceptions surrounding this condition as well as providing some practical advice on supporting better outcomes in the management of this condition.

Gout, a chronic inflammatory condition, is often undertreated despite its impact on quality of life. Misconceptions include it being only a lifestyle disease or affecting only older men. Effective management requires lifelong urate-lowering therapy and addressing both pharmacologic and non-pharmacologic factors.